Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 747 results
Found 747 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

N

Gandhi RT, Bosch RJ, Aga E, et al. "No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy." J. Infect. Dis.. 2010;201(2):293-6.
Gandhi RT, Coombs RW, Chan ES, et al. "No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy." J. Acquir. Immune Defic. Syndr.. 2012;59(3):229-35.
Kapadia SN, Wu C, Mayer KH, et al. "No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305." PLoS ONE. 2018;13(12):e0206577.
McLaughlin BE, Baumgarth N, Bigos M, et al. "Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach." Cytometry A. 2008;73(5):400-10.
McLaughlin BE, Baumgarth N, Bigos M, et al. "Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms." Cytometry A. 2008;73(5):411-20.
Lederman MM, Miller V, Weller I, Deeks SG. "A new approach for 'deep salvage' trials in advanced HIV infection." AIDS. 2007;21(12):1503-6.
Lockman S, Hughes M, Sawe F, et al. "Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial." PLoS Med.. 2012;9(6):e1001236.
Dong BJ, Zheng Y, Hughes MD, et al. "Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women." AIDS. 2012;26(7):833-41.
Cespedes MS, Aberg JA. "Neuropsychiatric complications of antiretroviral therapy." Drug Saf. 2006;29(10):865-74.
Parsons TD, Tucker KA, Hall CD, et al. "Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection." AIDS. 2006;20(12):1591-5.
Robertson KR, Su Z, Margolis DM, et al. "Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort." Neurology. 2010;74(16):1260-6.
Robertson KR, Miyahara S, Lee A, et al. "Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303." AIDS. 2016.
Mitsuya Y, Winters MA, W Fessel J, et al. "N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure." AIDS Res. Hum. Retroviruses. 2006;22(12):1300-5.

M

Stone ND, Dunaway SB, Flexner C, et al. "Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects." Antimicrob. Agents Chemother.. 2007;51(7):2351-8.
Verma A, Bradford Y, Verma SS, et al. "Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202." Pharmacogenet. Genomics. 2017;27(3):101-111.
Robertson K, Kumwenda J, Supparatpinyo K, et al. "A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings." J. Neurovirol.. 2011;17(5):438-47.
Motsinger AA, Ritchie MD, Shafer RW, et al. "Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study." Pharmacogenet. Genomics. 2006;16(11):837-45.
J Critchfield W, Lemongello D, Walker DH, et al. "Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection." J. Virol.. 2007;81(11):5460-71.
Schifitto G, Zhang J, Evans SR, et al. "A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment." Neurology. 2007;69(13):1314-21.
Shulman NS, Kassaye SG, Winters MA, Johnston E, Katzenstein DA. "More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175." J. Infect. Dis.. 2007;196(2):328-9; author reply 329-30.
Lederman MM, Penn-Nicholson A, Stone SF, Sieg SF, Rodriguez B. "Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption." Curr Opin HIV AIDS. 2007;2(1):56-61.
Gross R, Tierney C, Andrade A, et al. "Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial." Arch. Intern. Med.. 2009;169(13):1224-32.
Johnson BA, Ribaudo H, Gulick RM, Eron JJ. "Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times." Biometrics. 2013;69(3):732-40.
Svensson EM, Aweeka F, Park J-G, Marzan F, Dooley KE, Karlsson MO. "Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis." Antimicrob. Agents Chemother.. 2013;57(6):2780-7.
Mulligan K, Parker RA, Komarow L, et al. "Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial." J. Acquir. Immune Defic. Syndr.. 2006;41(5):590-7.
Canter JA, Haas DW, Kallianpur AR, et al. "The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy." Pharmacogenomics J.. 2008;8(1):71-7.
Grady BJ, Samuels DC, Robbins GK, et al. "Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384." J. Acquir. Immune Defic. Syndr.. 2011;58(4):363-70.
Hulgan T, Stein JH, Cotter BR, et al. "Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation." AIDS Res. Hum. Retroviruses. 2013;29(10):1293-9.
Abraham AG, Lau B, Deeks S, et al. "Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america." Am. J. Epidemiol.. 2011;174(6):727-35.
Pence BWells, Reif S, Whetten K, et al. "Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South." South. Med. J.. 2007;100(11):1114-22.

Pages